Quantoom Biosciences S.A.
Nivelles, Belgium
Purpose
To produce messenger Ribonucleic acid lipid nanoparticle products to support our vaccine development programs for the Low and Medium Income Countries.
Division
Global Health
Date
October 2023
Region Served
GLOBAL
Committed amount
$2,497,732
Grant topic
HIV, Vaccine Development
Duration (months)
15
Grantee location
Nivelles, Belgium
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.